The top five highlights for Day 1 at Arab Health 2015 taking place at the Dubai International Convention & Exhibition Centre from 26-29 January 2015:
H.H. Sheikh Mohammed Bin Rashid Al Maktoum, Prime Minister of the UAE and Ruler of Dubai officially inaugurated the 40th Arab Health Exhibition and Congress 2015. He was accompanied by H.E. Abul Rahman Bin Mohammed Al Owais, UAE Minster of Health along with other dignitaries who visited a selection of the exhibiting companies during their tour of the Arab Health Exhibition and Congress 2015.
3D printed baby heart was on display at the new Future of Surgery Zone at Arab Health. The 3D printed heart allowed doctors from New York- Presbyterian Morgan Stanley Children’s Hospital better plan to operate on a very complex and unique heart malformation. Medical staff used 3D printing technology to produce a 3D replica of the child’s heart in order to simplify the procedure.
Dr Abdishakur Abdulle, Associate Director, Public Health Research Center, NYU Abu Dhabi delivered a speech on childhood obesity and the impact on chronic diseases. He highlighted the role of parental involvement as a key factor in the deterrence and management of childhood obesity. Abdulle highlighted the results of a recent study on obesity among school children in Abu Dhabi, demonstrating that the incidence of overweight and obesity is approximately 20% among the age group 6-10 year old, and 40% among 11-19 years.
First Gulf Hypertension Conference is launched at Arab Health. Officially endorsed by the European Hypertension Society, the 1st Gulf Hypertension Conference is the new addition in the Arab Health Congress 2015 and will provide the most updated clinical and scientific data in the field of hypertension. The conference will run from 26-27 January. Delegates will learn the latest updates and the most recent advances in the field of hypertension and how to improve the patient’s management of this disease and its associated health impacts. The main goal of the conference is to elaborate on the extent of the disease and its impact on regional health plans.
Roche Diagnostics Middle East launched its latest innovations in in-vitro diagnostics, which included: cobas® 8100, cobas t 411, VENTANA HE 600. These latest laboratory solutions deliver quality and reliability for more accurate results in the areas of laboratory automation, coagulation, and histopathology. The new coagulation analyser, the cobas t 411, was designed to allow maximum flexibility for laboratories with low to medium throughput and a unique set of enhanced safety features to ensure robust and high quality results, every time for patients throughout the region.
Source: HK Strategies
Image Credit: Arab Health Online